Dianthus Therapeutics (NASDAQ:DNTH – Get Free Report) is expected to be issuing its quarterly earnings data before the market ...
Cantor Fitzgerald lifted their FY2025 EPS estimates for Dianthus Therapeutics in a research report issued on Thursday, March 13th. Cantor Fitzgerald analyst P. Stavropoulos now anticipates that the ...